Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-002562·Aclaris Therapeutics, Inc.
Schedule 13D ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: 2017-01-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,539,480
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-002562
- Form type
- SC 13D/A
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Jan 18, 2017
- Reporting period
- Jan 10, 2017
- Description
- Schedule 13D beneficial ownership